Dr. Ishita B. Sen MBBS, DRM,DNB (Nuclear Medicine) - video Dailymotion. Prelim Core 1: Better Health for Individuals. Peptide Receptor Radionuclide Therapy in India. Slide 1: Several researches and clinical trials have shown that Peptide Receptor Radionuclide Therapy PRRT is an exciting and effective advancement in the treatment of Neuroendocrine Tumors NETs. slide 2: Peptide Receptor Radionuclide Therapy PRRT is a recommended treatment option for patients with metastatic inoperable neuroendocrine tumors which are positive on Somatostatin Receptor Imaging Ga68-DOTATATE PET CT.
It is also recommended for NET patients who cannot undergo surgery and for patients who are not responding to other therapies. slide 3: The objective of Peptide Receptor Radionuclide Therapy PRRT is to provide symptom relief slow down or stop tumor progression to increase survival and improve quality of life. slide 4: Peptide receptor radionuclide therapy PRRT is fast proving to be paradigm shifting approach to the treatment of neuroendocrine tumors. slide 5: For more information on PRRT do call us at +91 98111 27080 or write to us at infonuclearmedicinetherapy.in or visit slide 6: Peptide Receptor Radionuclide Therapy for NET by Manav Sadhwani. Find Best Nuclear Medicine Physicians, Dosimetrists, Radiation Oncologists and Technicians in India. Everything you need to know about Alpha PSMA Therapy. According to the World Cancer Research Fund, Prostate Cancer is not only one of the most common malignancy in men but also one of the most commonly occurring cancer overall.
Prostate Cancer is also the fifth leading cause of death from cancer in men. Disease progression and metastatic spread signifies the beginning of a lethal form of the disease – metastatic castration resistant prostate cancer (mCRPCa). The incidence of prostate cancer increases proportionally with age, especially in men above 60 years of age. Studies have also shown that incidence of prostate cancer also depend on demographics and racial prevalence – prostate cancer has a low incidence in Asia (3-8 per 100,000 men per year), an intermediate incidence in Africa and Eastern Europe, and a higher incidence in North America and Western Europe.
So, the question that most patients and caregivers ask – What is Targeted Alpha Therapy or Alpha PSMA Therapy? Cost of Multiple Sclerosis Treatment in India at FMRI. The total duration of the uncomplicated stay in India is about 24 to 28 days.
The procedure is carried out on an in-patient basis at the world-class centre near New Delhi, the capital of India. The package cost of HSCT for MS oered by Fortis Memorial Research Institute (FMRI) is $30,000 US and that includes all costs for hospital stay (up to 28 days), doctors’ fee, various tests & consultations, medicines & other consumables, neuro-physiotherapy, food and laundry for both the patient and the patient’s caregiver. This cost also includes both airport pick-up and airport drop-off. Why Should You Choose FMRI for the Treatment of MS. Situated in Sector 44, Gurugram in Delhi NCR, Fortis Memorial Research Institute (FMRI) is a multi-super-specialty, quaternary care hospital with an enviable international faculty, reputed clinicians, including super-sub-specialists and speciality nurses, supported by cutting-edge technology.
A premium referral hospital, FMRI endeavours to the ‘Mecca of Healthcare’ for Asia-Pacific and beyond. This ‘Next Generation’ Institute is set on a spacious 11-acre campus with 1,000 beds is built on the foundation of ‘Trust’ and rests on four strong pillars: Talent, Technology, Service and Infrastructure. What Is Haematopoietic Stem Cell Transplant (HSCT) For Multiple Sclerosis. HSCT or Haematopoietic Stem Cell Transplant is not a new procedure; it has been used to treat cancer since the 1960s, however, it is relatively new treatment that attempts to control the eects of MS.
The objective of using HSCT as treatment for MS is to sort of ‘reset’ the immune system to prevent it from attacking the central nervous system. It is an intensive treatment pro- cedure that works by destroying the rogue immune system. In other words, the procedure involves the removal of the harmful immune cells that are attacking the brain and the spinal cord, and then using the patient’s own stem cells to effectively re-grow the body’s immune system. The point of the procedure is to ‘reset’ the immune system to prevent any further damage in the brain and the spinal cord. Since the patient’s own stem cells are used for the procedure, it is also known as an Autologous stem cell transplant.
Why is it Important to Start Early Treatment of Multiple Sclerosis. Before one begins to experience any symptoms of MS, early damage in the central nervous system can occur.
Studies have shown that one of the best chances of reducing long-term disability is during the early relapsing phase of the disease that’s characterized by inflammation – MS often causes more damage in the first year itself than in years five to 10. Further, given that all currently available medications primarily target inflammation, starting the treatment early helps to minimize this inflammation thereby reducing damage to nerve fibres and loss of brain tissue. Unfortunately, there is no cure for MS, however, medicines and certain lifestyle changes can help manage the condition. A good MS Treatment Plan must focus on four key areas: disease management, relapse management, symptom management and general health. Disease Management: Relapse Management: How is Multiple Sclerosis Diagnosed. MS is usually diagnosed and treated by a neurologist, however other medical professionals who specialize in neurology in conjunction with another area of medicine, such as radiology (a neuro-radiologist), ophthalmology (a neuro-opthalmologist) and psychology (neuro-psychologist), often assist in diagnosis and subsequent treatment protocols.
What are the Symptoms of Multiple Sclerosis. The symptoms of MS are unpredictable and they vary from person to person both in terms of type and severity.
The unpredictable symptoms might disappear or remit completely or they might persist and in some cases might even worsen over time. More so, one patient might experience just one or two of the possible symptoms and some other patient might experience many more. The frequency and duration of the symptoms vary and may include the following: This could be related to several factors including weakness, spasticity, loss of balance, sensory deficit and fatigue, however, these can be helped by certain medications and therapy (physical and assistive). For many MS Patients, this could be the first symptom – the onset of blurred vision, poor contrast or colour vision. What Causes Multiple Sclerosis. Multiple Sclerosis aects about 2.5 million people globally.
Geographically, MS is more prevalent in Northern Europe, North America, South-East Australia and New Zealand and is least prevalent in tropical and sub-tropical regions. On an average, one in 750 people have the possibility of getting Multiple Sclerosis. In recent years, the prevalence of Multiple Sclerosis has changed dramatically worldwide. While MS was believed to be more common in the Caucasians of Northern Europe and USA, however now, MS has been found to be present in the Indian subcontinent as well. Types of Multiple Sclerosis.